Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 2 |
2015 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Tofacitinib versus methotrexate in rheumatoid arthritis.
N Engl J Med. 2014 Jun 19;370(25):2377-86. doi: 10.1056/NEJMoa1310476.
N Engl J Med. 2014.
PMID: 24941177
Free article.
Clinical Trial.
Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results.
Myachikova VY, Maslyanskiy AL, Moiseeva OM, Vinogradova OV, Gleykina EV, Lavrovsky Y, Abbate A, Grishin SA, Egorova AN, Schedrova ML, Samsonov MY.
Myachikova VY, et al. Among authors: maslyanskiy al.
J Am Coll Cardiol. 2023 Jul 4;82(1):30-40. doi: 10.1016/j.jacc.2023.04.046.
J Am Coll Cardiol. 2023.
PMID: 37380301
Clinical Trial.
Item in Clipboard
Olokizumab, a monoclonal antibody against interleukin 6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by methotrexate: efficacy and safety results of a randomised controlled phase III study.
Nasonov E, Fatenejad S, Feist E, Ivanova M, Korneva E, Krechikova DG, Maslyanskiy AL, Samsonov M, Stoilov R, Zonova EV, Genovese M.
Nasonov E, et al. Among authors: maslyanskiy al.
Ann Rheum Dis. 2022 Apr;81(4):469-479. doi: 10.1136/annrheumdis-2021-219876. Epub 2021 Aug 3.
Ann Rheum Dis. 2022.
PMID: 34344706
Free PMC article.
Clinical Trial.
Item in Clipboard
Idiopathic recurrent pericarditis - a new orphan autoinflammatory disease? A retrospective analysis of cases of idiopathic recurrent pericarditis and a design of а double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of RPH-104 treatment in patients with idiopathic recurrent pericarditis.
Myachikova VY, Maslyanskiy AL, Moiseeva OM.
Myachikova VY, et al. Among authors: maslyanskiy al.
Kardiologiia. 2021 Feb 10;61(1):72-77. doi: 10.18087/cardio.2021.1.n1475.
Kardiologiia. 2021.
PMID: 33734057
Clinical Trial.
English, Russian.
Item in Clipboard
Effects of rituximab therapy on elastic properties of vascular wall in patients with progressive systemic sclerosis.
Maslyanskiy AL, Lapin SV, Kolesova EP, Penin IN, Cheshuina MD, Feist E, Konradi AO.
Maslyanskiy AL, et al.
Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-228. Epub 2014 Jan 30.
Clin Exp Rheumatol. 2014.
PMID: 24480389
No abstract available.
Item in Clipboard
Restrictive IgG antibody response against mutated citrullinated vimentin predicts response to rituximab in patients with rheumatoid arthritis.
Lindenberg L, Spengler L, Bang H, Dorner T, Maslyanskiy AL, Lapin SV, Ilivanova EI, Martinez-Gamboa L, Bastian H, Wittenborn E, Egerer K, Burmester GR, Feist E.
Lindenberg L, et al. Among authors: maslyanskiy al.
Arthritis Res Ther. 2015 Aug 13;17(1):206. doi: 10.1186/s13075-015-0717-z.
Arthritis Res Ther. 2015.
PMID: 26268352
Free PMC article.
Item in Clipboard
Cite
Cite